Stomach cancer risk after treatment for hodgkin lymphoma. - Wikidata - awgldk - TriplyDB

Stomach cancer risk after treatment for hodgkin lymphoma.

Stomach cancer risk after treatment for hodgkin lymphoma.

http://www.wikidata.org/entity/Q37165088

about

Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention Solid tumor second primary neoplasms: who is at risk, what can we do?Therapeutic radiation and the potential risk of second malignancies.Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).Therapy-associated polyposis as a late sequela of cancer treatment.Triple jeopardy for Hodgkin lymphoma survivors?Pancreatic cancer risk after treatment of Hodgkin lymphoma Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy Current knowledge and future research directions in treatment-related second primary malignancies.Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications.Increased stomach cancer risk following radiotherapy for testicular cancer Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions A case series of intestinal adenomatous polyposis of unidentified etiology; a late effect of irradiation?Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma.The concept and evolution of involved site radiation therapy for lymphoma.Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.Late sequelae in Hodgkin lymphoma survivors.Cholangiocarcinoma following external beam radiotherapy: A report of two cases.Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.Synchronous Hodgkin lymphoma and gastric adenocarcinoma: A rare case report and literature review.Carcinoma in the Remnant Stomach During Long-Term Follow-up After Distal Gastrectomy for Gastric Cancer: Analysis of Cumulative Incidence and Associated Risk Factors.Comparison of normal tissue dose calculation methods for epidemiological studies of radiotherapy patients.

P2860

Q26849435-F2CFD7FA-8D64-41D4-A5B7-683F613CAF27 Q27026266-E23644EA-F74C-4B4D-BF7E-F39107C2D617 Q30251822-B3FAE477-9284-4146-A7D2-F7BD252E199A Q31155582-2197A065-026D-496C-9BF3-2B0A38C9B715 Q33656467-8FBB05BC-51C8-4439-B6E8-6A988EB5C20D Q33917146-DCC3EE2E-0C1B-4D28-B5CB-9FD64C6D3ADB Q34250016-2E80F9F6-4F72-4FA6-8990-7A0BD2F931A5 Q34260518-736C1E0C-ACEA-43BC-96B0-E7928A9C4DFA Q34604460-1D9A3FE0-B6FA-4B6F-A8CC-93D0DACE672F Q35650402-39F92D25-0833-4463-B536-8F4424BB1E22 Q35677701-C4812C1E-4AB8-4613-BAD4-7CE21E01CD61 Q36031586-8537B18D-B5E5-4DCC-91B4-77A3B538EAE5 Q36184613-A440D566-0F6B-48B1-A819-0EC111EB026D Q37176188-E6367C7E-90C6-487E-B21C-24DB06269AF6 Q37216339-BF8F4344-A1EB-4B53-8DA4-370E0F121E16 Q38260182-43071A51-F085-4EFA-BD70-A3E9CF551048 Q38543470-1764A8F2-2063-46ED-8238-014A29B4965B Q38688797-E80897B6-A94C-44AE-9381-B83EFC746081 Q39001880-B6C7DB62-E9B6-403A-ABA0-3551DE4BB244 Q40152954-09EBB719-612B-4D96-BAAD-5CD3D5D931FE Q40168935-CBB159C9-4D80-4C61-A7EF-155BDA774C02 Q40978146-1AF37B89-5D92-4A24-8757-6FC3A085C510 Q42923398-D9C6E120-140F-404C-80E0-E58759359AD4 Q49578208-0176CC7D-92EF-4283-B0B7-EBE44C268D5F Q49636510-2F55ED2A-EC5B-4A67-B60F-7B9C92930406 Q50028759-23ED40C7-37B5-45D9-A750-9D6AFA8ECB9B Q52594532-208BE1B9-84EE-488D-810D-86CEF989818F

P2860

Stomach cancer risk after treatment for hodgkin lymphoma.

http://www.wikidata.org/entity/Q37165088

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stomach cancer risk after treatment for hodgkin lymphoma.

@en

Stomach cancer risk after treatment for hodgkin lymphoma.

@nl

type

label

Stomach cancer risk after treatment for hodgkin lymphoma.

@en

Stomach cancer risk after treatment for hodgkin lymphoma.

@nl

prefLabel

Stomach cancer risk after treatment for hodgkin lymphoma.

@en

Stomach cancer risk after treatment for hodgkin lymphoma.

@nl

P1433

Q37165088-C36B6267-4973-4B44-AFC9-04D428B81C20

P1476

Q37165088-025F1732-B6C6-4A2A-8A98-E7F63A65A1B7

P2093

Q37165088-0DCA6836-0F9A-4E89-85E9-D0780E692788

Q37165088-1D0A492E-17F1-43EE-B585-CBA04B8B1219

Q37165088-329FD6D5-9FD8-4BAF-94F1-7315FF258870

Q37165088-3DCF200D-12B9-484F-A4C4-1BCD812089C7

Q37165088-53F34AAB-94E2-4453-809B-DD8194CD9AFF

Q37165088-574EEEE8-4042-4705-8089-C2441D9394A0

Q37165088-69267466-333C-4F3A-8CA8-A5692BCBC6FF

Q37165088-76C87EE7-070C-4DE1-B9CC-F1828635FC32

Q37165088-82DA6812-09DD-42E7-8716-37FC9A2D8820

Q37165088-9416EAFB-1FD5-4EF7-8483-589A7CCE0AAE

P2860

Q37165088-06394091-B43F-451F-9042-F020397C224C

Q37165088-0A64B288-C593-4378-B01C-34C14071A173

Q37165088-12BB5BA1-5388-4A2F-84D4-09891EFD8A7F

Q37165088-4411C67E-E0BB-4759-82AE-08709A626406

Q37165088-52EC7D80-AA5F-4D42-B48A-879E84F03615

Q37165088-60510EDD-26D3-47D7-A8B5-CF6693717765

Q37165088-658DC877-31BC-4914-BF8A-FD92E80F67AE

Q37165088-71CF5111-6534-46BE-8385-595EBA0CBFB0

Q37165088-72E0D678-FE6C-4770-BE27-10A8D535C237

Q37165088-748D5558-6710-4B41-BFDF-38A448970EF2

P304

Q37165088-9418BB8F-1049-4915-8110-93C00A4215FD

P31

Q37165088-793D51E1-5FBD-42C7-B3C8-FB99BF56E820

P356

Q37165088-DD0E0A0E-D770-4DD6-981C-788C93AD3B3C

P407

Q37165088-DD7EB459-1F78-40B7-922A-ECDACCAF3650

P433

Q37165088-B8DA47E3-B971-421C-9CCF-7A8FD7F00095

P478

Q37165088-3AF2B006-25C9-4BEC-A425-6843C87A5427

P50

Q37165088-09EBAE31-81AB-4588-87DD-429C4E68DDE9

Q37165088-4EC24BF0-236F-4456-9ED3-5EFDA18C4BC8

Q37165088-6836D3E6-8E6E-4B15-AA14-CE21823A95E2

Q37165088-72163C9C-6188-4EDA-9231-BC6209530A8F

Q37165088-946BC428-E244-45F9-B3ED-3FECD7E72FFD

Q37165088-98970198-7D6C-4B81-87EE-8DA87EED09E4

Q37165088-B952E40B-D4BE-46A0-9393-4D524C297B8C

Q37165088-DB1E8B6D-809A-465F-A2D8-9978C6919E21

P577

Q37165088-800E3983-3F18-4A65-8777-0DCB5BC00EE3

P698

Q37165088-6DD10C34-38B7-4448-95C6-DE6D5C32C81F

P932

Q37165088-05F159E1-1B21-4EEE-9523-C4EA1BF19486

P356

JCO.2013.50.6832

P1433

Journal of Clinical Oncology

P1476

Stomach cancer risk after treatment for hodgkin lymphoma.

@en

P2093

Alexandra W van den Belt-Dusebout

http://www.w3.org/2001/XMLSchema#string

Berthe M Aleman

http://www.w3.org/2001/XMLSchema#string

Charles F Lynch

http://www.w3.org/2001/XMLSchema#string

David C Hodgson

http://www.w3.org/2001/XMLSchema#string

Eric J Holowaty

http://www.w3.org/2001/XMLSchema#string

Ethel S Gilbert

http://www.w3.org/2001/XMLSchema#string

Flora E van Leeuwen

http://www.w3.org/2001/XMLSchema#string

Graça M Dores

http://www.w3.org/2001/XMLSchema#string

Joseph F Fraumeni

http://www.w3.org/2001/XMLSchema#string

Leila Vaalavirta

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

Leukemia following Hodgkin's disease

Twenty years of MOPP therapy for Hodgkin's disease

Solid cancer incidence in atomic bomb survivors: 1958-1998

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study

Hodgkin's lymphoma in adults.

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

P304

3369-3377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2013.50.6832

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Frøydis Langmark

Sophie D. Fosså

Michael Hauptmann

P577

2013-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23980092

http://www.w3.org/2001/XMLSchema#string

P932

3770865

http://www.w3.org/2001/XMLSchema#string